Publikationen von Xixi Feng
Alle Typen
Zeitschriftenartikel (7)
2020
Zeitschriftenartikel
63 (1), S. 231 - 240 (2020)
A Novel Decalin-Based Bicyclic Scaffold for FKBP51-Selective Ligands. JOURNAL OF MEDICINAL CHEMISTRY 2018
Zeitschriftenartikel
12, 262 (2018)
Pharmacological Modulation of the Psychiatric Risk Factor FKBP51 Alters Efficiency of Common Antidepressant Drugs. FRONTIERS IN BEHAVIORAL NEUROSCIENCE 2017
Zeitschriftenartikel
8, 1725 (2017)
Stress-responsive FKBP51 regulates AKT2-AS160 signaling and metabolic function. NATURE COMMUNICATIONS 2016
Zeitschriftenartikel
59 (6), S. 2410 - 2422 (2016)
Rapid, Structure-Based Exploration of Pipecolic Acid Amides as Novel Selective Antagonists of the FK506-Binding Protein 51. JOURNAL OF MEDICINAL CHEMISTRY
Zeitschriftenartikel
8 (325), 325ra19 (2016)
The stress regulator FKBP51 drives chronic pain by modulating spinal glucocorticoid signaling. SCIENCE TRANSLATIONAL MEDICINE 2015
Zeitschriftenartikel
58 (19), S. 7796 - 7806 (2015)
Structure-Affinity Relationship Analysis of Selective FKBP51 Ligands. JOURNAL OF MEDICINAL CHEMISTRY
Zeitschriftenartikel
43 (14), S. 6983 - 6993 (2015)
FKBP51 employs both scaffold and isomerase functions to promote NF-kappa B activation in melanoma. NUCLEIC ACIDS RESEARCH Konferenzbeitrag (2)
2017
Konferenzbeitrag
27 (Suppl. 1), P.1.007, S. S8 - S8 (2017)
Sexually diergic effect of FK506 binding protein 51 (FKBP-51) inhibition on the ultradian rhythm of corticosterone in the rat. European College of Neuropsychopharmacology (ECNP) Workshop for Junior
Scientists in Europe, Nice, FRANCE, 09. März 2017 - 12. März 2017. EUROPEAN NEUROPSYCHOPHARMACOLOGY
Konferenzbeitrag
27, P.2.017, S. S39 - S39 (2017)
Unraveling the functional contribution of FKBP-51 in monoaminergic brain areas to stress vulnerability in mice. European College of Neuropsychopharmacology (ECNP) Workshop for Junior Scientists in Europe, Nice, FRANCE, 09. März 2017 - 12. März 2017. EUROPEAN NEUROPSYCHOPHARMACOLOGY